Phase II study of everolimus and temozolomide as 1-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms (NET G3 and NEC)
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
| Original language | English |
|---|---|
| Journal | Journal of Neuroendocrinology |
| Volume | 34 |
| Issue number | S1 |
| Pages (from-to) | 181-181 |
| Number of pages | 1 |
| ISSN | 0953-8194 |
| DOIs | |
| Publication status | Published - 2022 |
| Event | 19th Annual ENETS Conference on the Diagnosis and Treatment of Neuroendocrine Tumor Disease - Baltimore, Spain Duration: 10 Mar 2022 → 11 Mar 2022 |
Conference
| Conference | 19th Annual ENETS Conference on the Diagnosis and Treatment of Neuroendocrine Tumor Disease |
|---|---|
| Country | Spain |
| City | Baltimore |
| Period | 10/03/2022 → 11/03/2022 |
- neuroendocrine neoplasm, neuroendocrine carcinoma, high-grade gastroenteropancreatic, everolimus, temozolomide
Research areas
ID: 335686772